Australia markets closed

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
21.12-0.37 (-1.72%)
At close: 04:00PM EST
21.12 0.00 (0.00%)
After hours: 05:32PM EST
Full screen
Trade prices are not sourced from all markets
Previous close21.49
Open21.68
Bid0.00 x 2900
Ask0.00 x 4000
Day's range21.09 - 21.85
52-week range17.57 - 31.18
Volume899,981
Avg. volume613,254
Market cap2.448B
Beta (5Y monthly)0.68
PE ratio (TTM)25.45
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Corcept's (CORT) Q3 Earnings Beat Estimates, Revenues Miss

    Corcept's (CORT) earnings beat estimates in the third quarter of 2021 while revenues miss the same. The company tightens its revenue guidance for 2021.

  • Motley Fool

    Corcept Therapeutics Incorporated (CORT) Q3 2021 Earnings Call Transcript

    Statements during this call, other than statements of historical facts, are forward-looking statements based on our plans and expectations that are subject to risks and uncertainties which may cause actual results to differ materially from those such statements express or imply. The availability of competing treatments, including generic versions of Korlym, our ability to obtain acceptable prices or adequate insurance coverage and reimbursement for Korlym, risks related to the development of our product candidates, including their clinical attributes, regulatory approvals, mandates and oversights and other requirements, and the scope and protective power of our intellectual property.

  • Zacks

    Corcept Therapeutics (CORT) Q3 Earnings Top Estimates

    Corcept (CORT) delivered earnings and revenue surprises of 26.32% and -1.65%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?